Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.63 USD | +0.51% | -1.93% | +11.77% |
04-23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
04-23 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.77% | 1.39B | |
+4.94% | 109B | |
+11.00% | 105B | |
-0.38% | 22.25B | |
-11.91% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.04% | 16.85B | |
+3.92% | 13.76B | |
+35.95% | 12.46B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals, Ltd.
- Kiniksa Pharmaceuticals' Q4 Earnings, Revenue Increase